OR WAIT null SECS
© 2023 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2023 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
August 22, 2023
The collaboration partner for Willow is focused on more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste, in addition to looking for Willow’s expertise in developing and scaling key ingredients.
June 14, 2023
The new excipients manufacturing facility is expected to be completed in 2025.
November 03, 2022
The state of oral solid dose manufacturing is influenced by new approaches, novel technologies, and the structural evolution of the raw materials market.
July 03, 2022
Lack of toxicity data and poor physicochemical properties must be overcome.
May 03, 2022
Inhalation formulations are complex, and empirical data are essential for realizing optimal solutions.
March 10, 2022
Evonik has launched new EUDRATEC technology to improve solubility and performance of oral small molecules.
February 17, 2022
ImmunoGen and Eli Lilly and Company have entered into an agreement that gives Lilly exclusive rights to research, develop, and commercialize ADCs designed for targets selected by Lilly from ImmunoGen’s camptothecin technology.
February 11, 2022
China-based CDMO Asymchem acquires US-based chemical technology company Snapdragon.
January 18, 2022
In this episode of the Drug Solutions podcast, Chris Spivey, editorial director, and Meg Rivers, senior editor, interview experts on up-and-coming 2022 trends in the bio/pharma industry.
November 03, 2021
The researchers will use 3D printing to design novel flow reactors and static mixers.